Impact Biotech
About
ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) manufacturing capabilities.
Key facts
At-a-glance profile data
- Website
- impactbiotech.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 1996
- Employees
- 42
- Total funding
- $3M (Grant)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 16 Jul 2024 | Grant | $3M | EU EIC Accelerator |
Tech stack
Detected on impactbiotech.com, last scanned 11 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Impact Biotech raised?
Impact Biotech has raised a total of $3M in funding. The most recent round on record is Grant.
How many employees does Impact Biotech have?
Impact Biotech has approximately 42 people on record.